Inactivation patterns of p16/INK4A in oral squamous cell carcinomas

Experimental and Molecular Medicine

Volumn 36, Issue 2, 2004, Pages 165-171

  Lee, Jeong Keun ^a   Kim, Myung Jin ^b   Hong, Sam Pyo ^b   Hong, Seong Doo ^b  

^a Ajou University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Homozygous deletion; Oral squamous cell carcinoma; p16 INK4A; Promoter methylation

Indexed keywords

DNA; PROTEIN P16;

ARTICLE; CONTROLLED STUDY; DELETION MUTANT; DNA METHYLATION; DNA SEQUENCE; GENE; GENE INACTIVATION; GINGIVA TUMOR; HUMAN; HUMAN CELL; MOUTH CARCINOMA; P16 INK4A GENE; POINT MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

EID: 2442710439     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2004.23     Document Type: Article

References (28)

1. Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway in cell cycle control and cancer. Exp Cell Res 1997;237:1-6
2. Bonetta L. Tumor-suppressor genes. Open questions on p16. Nature 1994;370:180
3. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984;3:1151-7
4. Brenner AJ, Paladugu A, Wang H, Olopade OI, Dreyling MH, Aldaz CM. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer. Clin Cancer Res 1996;2:1993-8
5. Cody DT 2nd, Huang Y, Darby CJ, Johnson GK, Domann FE. Differential DNA methylation of the p16 INK4A/CDKN2A promoter in human oral cancer cells and normal human oral keratinocytes. Oral Oncol 1999;35:516-22
6. Drexler HG. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18, and p19 in human leukemia-lymphoma cells. Leukemia 1998;12:845-9
7. Eagle H. Propagation in a fluid medium of a human epidermoid carcinoma, strain KB (21811). Proc Soc Exp Biol Med 1955;89:362-4
8. Eagle H, FoleyGE. Cytotoxicity in human cell cultures as a primary screen for the detection of anti-tumor agents. Cancer Res 1958;18:1017-25.
9. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-6
10. Hertwig S, Strauss M. The retinoblastoma protein- a master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem 1997;246:581-601
11. Kim DM, Yang K, Yang BS. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A. Exp Mol Med 2003;35:421-30
12. INK4a in primary tumors and cell lines of head and neck squamous cell carcinoma. Mol Cells 2000;10:557-65
13. Liggett WH Jr, Sidransky D. Role of the p16 tumor suppressor gene. J Clin Oncol 1998;16:1197-206.
14. INK4 in human ovarian tumours. Br J Cancer 1997;76:146-9
15. Mead LJ, Gillespie MT, Irving LB, Campbell LJ. Homozygous and hemizygous deletions of 9p centromeric to the interferon genes in lung cancer. Cancer Res 1994;54:2307-9
16. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 1994;9:3375-8
17. INK4A protein induction by 5-aza 2′ deoxycitidine. Oncogene 1995;11:1211-6
18. Pardee AB. G1 events and regulation of cell proliferation. Science 1989;246:603-8
19. Rheinwald JG, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 1981;41:1657-63
20. Salzman NP. Animal cell cultures. Science 1961;133:1559-65
21. Sartor M, Steingrimsdottir H, Elamin F, Gaken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. Br J Cancer 1999;80:79-86
22. Sellers WR, Kaelin WG Jr. Role of the retinoblastoma protein in the pathogenesis of human cancer. J Clin Oncol 1997;15:3301-12
23. Stein GH, Beeson M, Gordon L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 1990;249:666-9
24. Tsutsumi M, Tsai YC, Gonzalgo ML, Nichols PW, Jones PA. Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer. Oncogene 1998;17:3021-7
25. Wei G, Lonardo F, Ueda T, Kim T, Huvos AG, Healey JH, Ladanyi M. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons. Int J Cancer 1999;80:199-204
26. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-30
27. Wu CL, Roz L, McKown S, Sloan P, Read AP, Holland S, Porter S, Scully C, Paterson I, Tavassoli M, Thakker N. DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas. Genes Chromosomes Cancer 1999;25:16-25
28. Zhang SY, Klein-Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, Carson DA, Ridge JA, Goodrow TL. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 1994;54:5050-3